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Abstract 
Background: Persistent hyperlactatemia is particularly difficult to interpret in septic shock. Besides hypoperfusion, 
adrenergic‑driven lactate production and impaired lactate clearance are important contributors. However, clinical 
recognition of different sources of hyperlactatemia is unfortunately not a common practice and patients are treated 
with the same strategy despite the risk of over‑resuscitation in some. Indeed, pursuing additional resuscitation in non‑
hypoperfusion‑related cases might lead to the toxicity of fluid overload and vasoactive drugs. We hypothesized that 
two different clinical patterns can be recognized in septic shock patients through a multimodal perfusion monitoring. 
Hyperlactatemic patients with a hypoperfusion context probably represent a more severe acute circulatory dysfunc‑
tion, and the absence of a hypoperfusion context is eventually associated with a good outcome. We performed a 
retrospective analysis of a database of septic shock patients with persistent hyperlactatemia after initial resuscitation.
Results: We defined hypoperfusion context by the presence of a ScvO2 < 70%, or a P(cv‑a)CO2 ≥6 mmHg, or a CRT 
≥4 s together with hyperlactatemia. Ninety patients were included, of whom seventy exhibited a hypoperfusion‑
related pattern and 20 did not. Although lactate values were comparable at baseline (4.8 ± 2.8 vs. 4.7 ± 3.7 mmol/L), 
patients with a hypoperfusion context exhibited a more severe circulatory dysfunction with higher vasopressor 
requirements, and a trend to longer mechanical ventilation days, ICU stay, and more rescue therapies. Only one of the 
20 hyperlactatemic patients without a hypoperfusion context died (5%) compared to 11 of the 70 with hypoperfu‑
sion‑related hyperlactatemia (16%).
Conclusions: Two different clinical patterns among hyperlactatemic septic shock patients may be identified accord‑
ing to hypoperfusion context. Patients with hyperlactatemia plus low ScvO2, or high P(cv‑a)CO2, or high CRT values 
exhibited a more severe circulatory dysfunction. This provides a starting point to launch further prospective studies to 
confirm if this approach can lead to a more selective resuscitation strategy.
Keywords: Septic shock, Hyperlactatemia, Resuscitation, Hypoperfusion, Central venous oxygen saturation,  
Central venous‑arterial PCO2 gradient, Capillary refill time
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Background
Sepsis-3 consensus defined septic shock as vasopressor 
requirement to maintain mean arterial pressure (MAP) 
>65 mmHg and a serum lactate level >2 mmol/L despite 
fluid resuscitation [1], and claimed that these criteria 
will identify patients with a homogeneous high risk of 
death, allegedly in excess of 40% [1]. Unfortunately, nei-
ther this new definition [1], or the Surviving Sepsis Cam-
paign (SSC) [2] recognizes the heterogeneous sources of 
lactate in septic shock or the existence of different clini-
cal patterns among hyperlactatemic patients. Therefore, 
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normalization of lactate is recommended as a goal for 
septic shock resuscitation under the assumption that tis-
sue hypoxia is the main source of lactate generation [2].
However, persistent hyperlactatemia is particularly dif-
ficult to interpret in the clinical setting. Besides hypoper-
fusion, adrenergic-driven aerobic lactate production and 
impaired hepatic lactate clearance have been suggested as 
important contributors [3–5]. Recognizing a clinical pat-
tern of hypoperfusion-related hyperlactatemia appears 
as highly relevant since optimizing systemic blood flow 
in this setting could revert ongoing hypoperfusion and 
improve prognosis [6, 7]. In contrast, pursuing additional 
resuscitation in non-hypoperfusion-related cases might 
lead to the toxicity of fluid overload and excessive vaso-
active drugs, eventually increasing morbidity or mortality 
[4].
Recognition of clinical patterns among septic shock 
patients with persistent hyperlactatemia is unfortunately 
not a common practice around the world, and hyper-
lactatemic patients are treated with the same strategy 
despite the risk of over-resuscitation in some. Never-
theless, a multimodal perfusion monitoring could aid in 
identifying a hypoperfusion context [4]. Indeed, the com-
bination of hyperlactatemia with pCO2-related markers 
of tissue hypoxia provides a stronger prognostic signal 
than either one alone [8]. In a lactate-driven resuscita-
tion protocol, Jansen et  al. [7] recommended systemic 
flow optimization exclusively in hyperlactatemic patients 
with concomitant low central venous oxygen saturation 
(ScvO2). Hernandez et  al. [9] demonstrated that vari-
ables such as ScvO2, central venous-arterial PCO2 gra-
dient (P(cv-a)CO2) and peripheral perfusion as assessed 
by the capillary refill time (CRT) exhibit a very fast nor-
malization rate in relation to systemic flow optimization, 
whereas lactate shows a biphasic response with an initial 
rapid improvement in parallel with the above-mentioned 
variables, followed by a much slower trend thereafter. 
Thus, a concomitant low ScvO2, or high P(cv-a)CO2, or 
an abnormal peripheral perfusion defines a hypoperfu-
sion context on which increasing systemic flow may con-
tribute to serum lactate decrease.
Is the opposite true? Can resuscitation be safely 
stopped in hyperlactatemic septic shock patients with-
out a hypoperfusion context? A recent pilot study by van 
Genderen et  al. [10] indeed suggests that stopping fluid 
resuscitation when peripheral perfusion is normalized is 
not only safe, but also associated with less positive fluid 
balances and organ dysfunctions in septic shock patients 
with hyperlactatemia. However, this aspect is currently 
being addressed by ongoing studies.
We hypothesized that two different clinical patterns 
can be recognized in septic shock patients as defined 
by sepsis-3 consensus, according to the presence of a 
hypoperfusion context. Hyperlactatemic patients with 
a hypoperfusion context probably represent a more 
severe acute circulatory dysfunction, and the absence 
of a hypoperfusion context is eventually associated with 
a good outcome. We designed this retrospective proof-
of-concept study to test our primary hypothesis. If this 
proves to be true, then it could be safe to launch a pro-
spective study testing a restrictive resuscitation strategy 
in the latter, while concentrating resuscitation efforts in 
the former.
Methods
We evaluated all septic shock patients admitted to our 
intensive care unit (ICU) at the University Hospital of 
the Pontificia Universidad Católica de Chile during the 
18-month period from July 2013 to December 2014. 
These patients were managed according to a local algo-
rithm [9] and entered into a prospective dataset. The 
Institutional Review Board of our Institution approved 
this study and waived the need of an informed consent 
because of the retrospective observational nature of the 
study (CEC-MEDUC; 16-182, 2016).
Study population
Patients ≥18 years old were included if they presented: (a) 
septic shock according to sepsis-3 Definitions (require-
ment of vasopressors to sustain MAP ≥65  mmHg and 
hyperlactatemia >2  mmol/l after initial fluid resuscita-
tion) [1]; (b) concomitant values for ScvO2, P(cv-a)CO2 
and CRT; (c) full commitment for resuscitation; and (d) 
complete follow-up in the dataset and medical charts 
until hospital discharge.
Study protocol
Hypoperfusion context was defined by the presence of a 
ScvO2 <70%, or a P(cv-a) CO2 ≥6 mmHg, or a CRT ≥4 s 
together with hyperlactatemia after initial fluid resuscita-
tion in the ICU. Patients without any abnormality were 
classified as with a non-hypoperfusion context. Both sub-
groups were compared in clinical-demographic data and 
severity scores at baseline; and macrohemodynamic and 
perfusion parameters, hemodynamic interventions and 
main outcomes.
All patients were managed according to our local algo-
rithm aimed at macrohemodynamic stabilization and 
improvement of hypoperfusion [9]. A central venous 
catheter and an arterial line were inserted in all. A pul-
monary artery catheter was recommended for those with 
a concomitant acute respiratory distress syndrome and/
or past medical history of heart failure. Perfusion targets 
were normalization of ScvO2, P(cv-a)CO2, CRT and mot-
tling, and a clear tendency to a decrease in arterial lactate 
levels. The algorithm was described elsewhere [9], but 
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briefly preload optimization guided by dynamic predic-
tors of fluid responsiveness was the first step to improve 
systemic blood flow. Pulse pressure variation was the pre-
ferred dynamic parameter when feasible. Echocardiogra-
phy was not routinely performed during the study period 
except as an aid to assess preload status through inferior 
vena cava distensibility when necessary. Fluid challenges 
were repeated until the perfusion targets mentioned 
above were normalized, or the selected dynamic predictor 
of fluid responsiveness turned negative, or a safety limit 
of an increase in central venous pressure ≥5 mmHg after 
a fluid bolus was reached. Norepinephrine (NE) was the 
vasopressor of choice and adjusted to a MAP ≥65 mmHg. 
Low-dose dobutamine or milrinone was restricted to 
patients with persistent or worsening hypoperfusion after 
preload optimization. Hemoglobin concentrations were 
maintained at 8  g/dL or higher to optimize arterial O2 
content. Mechanical ventilation settings were adjusted 
according to current recommendations. High-volume 
hemofiltration (HVHF) was used as rescue therapy in 
patients evolving with refractory septic shock.
Statistical analysis
Categorical data were analyzed with Chi-square, t test for 
paired samples and Wilcoxon test when appropriate. We 
tested the discriminating value of each perfusion variable 
alone or in combination.
All data are presented as mean  ±  standard deviation 
(SD). All reported p values are two-sided, with a signifi-
cant alpha level at 5%. STATA 13 (STATA Corp, Tx, USA) 
statistical package was used for analysis.
Results
A total of 116 septic shock patients were admitted during 
the study period. Of these, ninety patients (57% female, 
mean age 66 ±  16  years) fulfilling the inclusion criteria 
were analyzed. Twenty-six patients were excluded from 
further analysis because of normal lactate levels at ICU 
admission (7), absence of data on one of the three param-
eters that define hypoperfusion context (10), no full com-
mitment for full resuscitation (4), or early transfer to 
other hospitals (5).
The main sepsis sources were abdominal (n = 46), pul-
monary (n =  21), urinary (n =  15), and others (n =  8). 
Seventy patients exhibited a hypoperfusion context after 
initial resuscitation in the ICU, and 20 did not. The main 
clinical, demographic and physiological characteris-
tics according to subgroups at baseline are presented in 
Table 1.
Although lactate values at baseline (4.8  ±  2.8 vs. 
4.7 ± 3.7 mmol/L) were comparable, the hypoperfusion-
context subgroup presented a more severe circulatory 
dysfunction as expressed by higher NE requirements and 
a trend to a worse SOFA score (Table  1). As expected 
according to our local algorithm, patients categorized as 
with a hypoperfusion context received more dobutamine 
(31 vs. 5%; p  <  0.01), and tended to receive more fluids 
(6732 ± 2524 vs. 5940 ± 2756 ml; p = 0.2).
Lactate decreased at the same rate in both groups (6 h 
lactate: 4 ± 2.7 vs. 3.9 ± 2.7 mmol/l, p = 0.9; 24 h lactate: 
3.2 ± 3.0 vs. 2.7 ± 2.1 mmol/l, p = 0.4; 6 h lactate clear-
ance: 13 ± 39 vs. 7 ± 48%, p = 0.58; 24 h lactate clear-
ance: 27 ± 61 vs. 32 ± 39%, p = 0.7). However, within the 
hypoperfusion-context subgroup, 24-h lactate levels sig-
nificantly decreased only in survivors with no change in 
non-survivors (Additional file 1: Figure S1). In addition, 
P(cv-a)CO2 (7.6 ± 2.6 to 4.4 ± 2.3 mmHg; p < 0.001) and 
CRT (5.4 ± 2.2 to 3.1 ± 2.9 s; p < 0.001) decreased only 
in survivors.
Regarding main outcomes, patients with a hypoperfu-
sion context exhibited a more severe circulatory dysfunc-
tion requiring higher NE doses at 6 h, and tended to have 
longer duration of mechanical ventilation, and higher use 
of HVHF as rescue therapy, in addition to longer ICU 
and hospital stays (Fig.  1). Eleven of 70 patients (16%) 
with a hypoperfusion context died as compared to only 
one of twenty in those without, although this difference 
was not significant.
The effect of using the criterion of “at least one abnor-
mal perfusion parameter” among the three considered for 
Table 1 Clinical, demographic, severity scores, perfu-
sion and  hemodynamic variables at  baseline according 
to hypoperfusion context
A p < 0.05 was considered as significant
Values are expressed as mean ± SD
APACHE Acute Physiology and Chronic Health Evaluation, SOFA Sequential Organ 
Failure Assessment, MAP mean arterial pressure, SAP systolic arterial pressure, 
DAP diastolic arterial pressure, P(cv-a)CO2 central venous-arterial pCO2 gradient, 






Age (years) 66 ± 17 65 ± 13 0.9
Charlson index 1.9 ± 2.2 1.6 ± 0.3 0.7
APACHE II score 22 ± 7 20 ± 5 0.2
SOFA score 9.5 ± 3.8 8.4 ± 2.6 0.1
Heart rate (beats/s) 104 ± 23 115 ± 24 0.07
MAP (mmHg) 75 ± 19 77 ± 21 0.6
SAP (mmHg) 108 ± 27 111 ± 27 0.6
DAP (mmHg) 59 ± 14 57 ± 12 0.6
Arterial lactate 
(mmol/L)
4.8 ± 2.8 4.7 ± 3.7 0.9
ScvO2 (%) 71.3 ± 9.5 74.8 ± 7 <0.05
P(cv‑a) CO2 7.6 ± 2.5 5.5 ± 2.2 <0.001
CRT (s) 5.4 ± 2.3 4.2 ± 2.6 <0.001
NE (mcg/kg/min) 0.19 ± 0.24 0.09 ± 0.11 <0.05
Page 4 of 6Alegría et al. Ann. Intensive Care  (2017) 7:29 
defining a hypoperfusion context, as compared to each 
one individually to discriminate survivors versus non-
survivors is shown in the distributional Fig. 2. Although 
the purpose of this figure is only to show visually the 
impact of using different criteria, it appears that the best 
discriminating capacity is for “at least one abnormal per-
fusion parameter.” In addition, the effect of testing dif-
ferent combinations of these three perfusion parameters 
(ScvO2, P(cv-a)CO2, and CRT) to define hypoperfusion 
context and the effect on outcomes variables is shown in 
Additional file 2: Table S1.
Discussion
Our main finding is that a multimodal perfusion moni-
toring in sepsis-3 septic shock patients may aid to differ-
entiate two clinical patterns according to the presence of 
a hypoperfusion context. Patients with hyperlactatemia 
associated with either low ScvO2, or high P(cv-a)CO2, or 
high CRT values exhibit a more severe circulatory dys-
function. The absence of a hypoperfusion context among 
septic shock patients with hyperlactatemia is associated 
with a good outcome. These findings do not support 
sepsis-3 statement that the new septic shock definition 
identifies a group of patients with a homogenous high 
mortality risk [1]. On the other hand, they provide the 
basis for the development of a prospective study aimed 
at testing a safe restrictive fluid resuscitation strategy in 
septic shock patients without a hypoperfusion context, 
while concentrating resuscitation efforts in those with 
hypoperfusion criteria. The presence of a low ScvO2 in 
the setting of persistent hyperlactatemia clearly indi-
cates an imbalance in the oxygen transport/oxygen con-
sumption relationship [7, 11]. A high Pcv–aCO2 might 
identify patients who remain inadequately resuscitated 
and constitutes a marker of global perfusion that could 
aid in identifying a hypoperfusion-related hyperlac-
tatemia [12, 13]. Assessment of peripheral perfusion 
may provide additional physiological information. An 
abnormal peripheral perfusion may be caused by adren-
ergic-induced skin vasoconstriction secondary to a low 
systemic blood flow and should prompt a reassessment 
of the hemodynamic state, in particular the volume sta-
tus [10, 14]. Under the best of our knowledge, this is the 
first study that uses the three variables together to define 
a hypoperfusion context, an aspect that has to be high-
lighted because of the individual limitations of every iso-
lated parameter. As a matter of fact, ScvO2 can be normal 
in the setting of severe microcirculatory abnormalities [4, 
12], Pcv-aCO2 might be normal in hyperdynamic states 
even in the presence of tissue hypoxia [13], and periph-
eral perfusion may be difficult to assess under some cir-
cumstances. However, our results show that when the 
three are normal in hyperlactatemic patients, mortality 
as well as morbidity is very low, and thus the presence of 
tissue hypoxia as the cause of hyperlactatemia appear as 
unlikely in this setting, although of course it cannot be 
ruled out completely.
Remarkably, lactate values were comparable between 
subgroups at baseline (mean of 4.7–4.8 mmol/l) at a level 
where patients would not only have been diagnosed as 
septic shock according to sepsis-3 criteria [1], but also 
considered for inclusion in the EDGT trial [11]. How-
ever, adding hypoperfusion-context criteria to clinical 
assessment might aid in differentiating two clinical pat-
terns with marked different risks as demonstrated by our 
study. Of course our design does not allow us to estab-
lish sensitivity or specificity or predictive value of these 
criteria to track real hypoxia-related hyperlactatemia, 
but at least our findings are hypothesis-generating, and 
might build up the foundations for future trials on septic 
shock patients that focus resuscitation efforts on selected 
populations. Anyway, hypoxia is a cellular event that is 
hardly diagnosed by clinical means. In the past, lactate/
pyruvate ratio or more recently, the venous-arterial CO2 
Fig. 1 Severity criteria to compare hyperlactatemic patients 
without versus with a hypoperfusion context. a Mean norepineph‑
rine doses for both subgroups at baseline, 6 and 24 h. Black boxes 
describe hypoperfusion‑context subgroup; white boxes represent 
non‑hypoperfusion context subgroup. b Comparison of the use of 
rescue therapy and several outcome parameters between subgroups. 
HVHF high‑volume hemofiltration, Mortality hospital mortality, MV 
mechanical ventilation, ICU intensive care unit, LOS length of stay
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to arterial-venous O2 content difference ratio have been 
proposed for this purpose, although both ratios have 
important theoretical and practical drawbacks [3, 8]. 
Our study has several drawbacks related to its retrospec-
tive nature and inclusion of a relatively small number of 
patients. Several variables exhibited a trend to be worse 
in the hypoperfusion-related subgroup but were short of 
significance, thus weakening our conclusions. Addition-
ally, each variable proposed to define a hypoperfusion 
context has its own limitations. We also did not calculate 
the lactate/pyruvate or venous-arterial CO2 to arterial-
venous O2 content difference ratios, closers indicators of 
tissue hypoxia according to several physiological studies. 
The parallel decrease in lactate levels in subgroups with 
versus without a hypoperfusion context could be viewed 
as contradictory, but when addressing this aspect more 
profoundly, the rate of decrease in lactate values in pre-
sumably hypoperfused patients was slowed by the perfor-
mance of non-survivors who tended to increase lactate 
over time as compared to survivors (Additional file  1: 
Figure S1). This highlights the difficulties in interpreting 
lactate dynamics in septic shock patients subjected to a 
nonselective resuscitation strategy, as was also observed 
in another previous study [7]. However, despite these 
limitations, we could effectively differentiate two clini-
cal patterns among hyperlactatemic septic shock patients 
when applying a monitoring model that includes three 
easily assessable perfusion-related parameters.
Fig. 2 Distributional figure: the figure displays different plausible allocation of patients under *four* distinctive hypoperfusion‑context descrip‑
tors and their relationship with outcome in hyperlactatemic septic shock patients. The figure shows the distribution of patients according to the 
presence of abnormal ScvO2, CRT, and P(cv‑a)CO2, and its relationship with hospital mortality where white and black circles represent survivors and 
non‑survivors, respectively. a Comparing patients with normal perfusion criteria (bottom) versus those with at least one abnormal criterion (top). b 
Comparing patients with normal (bottom) versus abnormal ScvO2 (top). c Comparing patients with normal (bottom) versus abnormal CRT (top). d 
Comparing patients with normal (bottom) versus abnormal P(cv‑a)CO2 (top). The p values represent the difference in mean lactate values among 
patients fulfilling or not the descriptors tested. No difference in lactate values was observed when using any of these descriptors although there are 
trends for difference in survival, especially when using the “at least one abnormal perfusion parameter” criterion as shown in the first column. ScvO2 
central venous oxygen saturation, CRT capillary refill time, P(cv‑a)CO2 central venous‑to‑arterial carbon dioxide difference
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Conclusion
A mutimodal perfusion monitoring can identify two 
clinical patterns among hyperlactatemic septic shock 
patients according to widely used hypoperfusion-related 
criteria. Patients with hyperlactatemia plus low ScvO2, 
or high P(cv-a)CO2, or high CRT values exhibit a more 
severe circulatory dysfunction with increased morbidity. 
This provides a starting point to launch further prospec-
tive studies to confirm if this approach can lead to a more 
rational and selective resuscitation strategy.
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